Tuesday's Gone With The Wind
Entry 1 8:48 a.m.
Bi-weekly Chemo Week Much Scarier than Shark Week
Thursday is chemotherapy for Jenny. Her friend Amelia is taking her. We are saving my sick and vacation days for vacation and cataclysm. I fucking hate chemotherapy week. Watching the cancer eat away at Jenny is terrible enough--and not as bad as it could be given her fortitude and resilience, But chemo and the attendant drugs that go along with it are, well, hell. She is out of it for the first 24-48 hours following chemo. The following 2 days are touch and go, mostly go. We are moving forward as if everything is going to continue, as if the deluge has been forestalled indefinitely. The packing continues apace. I secured a home insurance binder this morning for the new home. A moving company--Jenny's girlfriends recommended a firefighter owned company (imagine if I hired a nurse operated moving company, holy shit)--is coming today to provide an estimate. My sister Jane volunteered to come show the estimator around, she is so selfless!
The academic papers keep rolling into my inbox. I am worried, as always. While treatment has somewhat improved over the last 18 years, people with Jenny's exact diagnosis still mostly die within 4-6 months. So, all of the tooting of the improvements in the journals don't mean much. Here is the latest I read, from an article written in 2003:
". . . Determination of CA 19-9 provides faster evidence of response than conventional imaging procedures. With decreasing CA 19-9 values, objective progress of tumour is improbable, and treatment may be continued. In patients with an increase of CA 19- 9 or with a decrease < 20%, prognosis is extremely poor and with the exception of cases with significant improvement of clinical benefit response, further chemotherapy with gemcitabine seems to be of questionable value. In the setting of clinical decision-making, CA 19-9 kinetics may help to reduce the continuation of ineffective chemotherapy and the number of costly imaging procedures. Thus, rational implementation of CA 19-9 determination during chemotherapy of pancreatic cancer may induce a substantial reduction in treatment-related costs."1
Eternity's Gate
Good old cost-benefit analysis. If I were a betting man, I would wager we will cease the gemcitabine after this 48 weeks comes to an end July 29. If it isn't proposed, I will have questions for Dr. P. I am praying we can have one last Christmas together with the girls.
Entry 2 12:54 p.m.

She’s gaslighting you. He’s gaslighting her.
ReplyDeleteNailed it.
Delete